PCR技術的全球市場：市場規模和佔有率分析（依產品、技術、應用和最終用戶）、工業需求預測（截至2030年）

全球PCR技術市場預計將以8.4%的複合年增長率成長，到2023年達到137.093億美元，到2030年達到236.725億美元。

這一增長是由遺傳性疾病和傳染病發病率的增加以及用於改進診斷技術的資金增加所推動的。此外，疾病早期診斷意識的提高和產品開發將進一步支持該行業的擴張。

北美市場領先

到 2023 年，北美地區將佔據該行業的 40% 佔有率，預計在整個十年內仍將保持最大地位。這是由於傳染病的日益普及、大公司引進改進的 PCR 機器和耗材以及醫療基礎設施的發展。

依細分市場的見解

2023年，試劑耗材品類將佔據產業最大佔有率，達到70%的佔有率，這也是近10年來最大的。這是因為 PCR 檢測經常不僅使用試劑，還使用耗材。

實時 PCR 類別預計將在 2023 年引領行業，並在未來幾年以 8% 的驚人速度進一步發展。它是一種在全球廣泛採用的方法，適用於多種應用，包括基因表現分析、診斷測試開發和癌症表型分析。

診斷類別所佔佔有率最大。這是因為 PCR 檢測是診斷某些基因變化和傳染病的一種非常精確的方法。

本報告分析了全球PCR技術市場，包括市場的基本結構、最新情況、主要推動和抑制因素以及全球、依地區和主要國家的市場規模前景（價值基礎，2017-2030年） ），依產品、技術、應用和最終用戶劃分的詳細趨勢、市場競爭的現狀以及主要公司的概況。

目錄

第一章 調查範圍

第二章 研究方法

第3章執行摘要

第四章 市場指標

第五章 產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/課題
  • 促進/抑制因素影響分析
• 新型冠狀病毒感染（COVID-19）的影響
• 波特五力分析

第六章 世界市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依技術分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）
• 市場收入：依地區（2017-2030）

第七章 北美市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依技術分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）
• 市場收入：依國家分類（2017-2030）

第八章歐洲市場

第九章亞太市場

第十章 拉丁美洲市場

第十一章 中東和非洲（MEA）市場

第十二章 美國市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依技術分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）

第十三章 加拿大市場

第十四章 德國市場

第十五章 法國市場

第十六章 英國市場

第十七章 義大利市場

第十八章 西班牙市場

第十九章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章南非市場

第28章 阿拉伯聯合大公國（UAE）市場

第29章競爭格局

• 市場參與者及其提供的產品/服務的列表
• 主要企業競爭基準
• 主要公司的產品基準
• 近期策略發展狀況

第三十章 公司簡介

• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Takara Bio USA Inc.
• Agilent Technologies Inc.
• Standard BioTools Inc.
• Danaher Corporation
• Abbott Laboratories
• Merck Life Science Private Limited
• Becton, Dickinson and Company
• Eppendorf AG

第31章附錄

The PCR technologies market generated USD 13,709.3 million in 2023, which will increase to USD 23,672.5 million, powering at an 8.4% CAGR, by 2030.

The growth is because of the increasing genetic disorders and infectious disease occurrence and rising funding to improve diagnostic technologies. Furthermore, the rising consciousness about early disease diagnosis and development in products will further assist this industry expansion.

The surging need for digital PCR kits and assays, consumables, and reagents, is a major driver for this industry, particularly since the pandemic. As the pandemic broke out, the need for digital PCR tests from life sciences and biotechnology firms substantially increased.

PCR tests were performed in various kinds of settings, from hospitals and airports to shopping malls and stadia, to detect and quarantine patients with the virus.

Additionally, COVID-19 is an important factor for the acceptance of the PCR technology as it was made a mandatory test for flyers across various nations.

The Indian government, in December 2022, made RT-PCR testing for COVID-19 compulsory for passengers coming from China, Japan, Hong Kong, Thailand, Singapore, and South Korea from January 2023 onward.

Moreover, France, in January 2023, prolonged its mandate for COVID-19 tests for people arriving from China. Further, France has urged the other 26 EU member states to test Chinese travelers for the virus.

The U.S. has also placed compulsory COVID-19 tests for individuals arriving from China. Additionally, the U.S. Centers for Disease Control and Prevention said that the nation's citizens should hold plans to travel to Hong Kong, Macau, and China until further notice.

North America is Leading Market

North America led the industry in 2023, with a 40% share, and it will remain the largest throughout this decade. This can be because of the increasing prevalence of infectious diseases, the introduction of improved PCR instruments and consumables by the key players, and the development of the healthcare infrastructure.

Moreover, the growing partnerships between businesses are also aiding the industry expansion.

For example, Takara Bio USA Inc., in October 2022, collaborated with BioExcel Diagnostics Laboratory to develop a new technique for detecting infectious illnesses that result in syndromes and authenticate its efficiency.

Segmentation Insights

In 2023, the reagents and consumables category was the largest contributor to the industry, with a 70% share, and it will remain the largest during this decade. This can be ascribed to the regular use of consumables as well as reagents for PCR testing.

The real-time PCR category led the industry in 2023, and will further advance at a significant rate, of 8%, in the coming years. It is an extensively employed method globally for different applications, including gene expression analysis, diagnostic test development, and cancer phenotyping.

The diagnostics category accounted for the largest share. This is because PCR tests are a very precise means to diagnose specific genetic changes and infectious ailments.

Competition Analysis

Major players in this industry are entering into mergers and acquisitions to reach more people, increase their revenue, and improve the technology of their products.

Bio-Rad Laboratories Inc., in August 2022, signed a deal to acquire all the outstanding shares of Curiosity Diagnostics Sp. Z. o. o.'s for USD 170 million.

The contract provided Bio-Rad access to Curiosity Diagnostics' under-development sample-to-answer, rapid polymerase chain reaction system for molecular diagnostics.

With the rising funding to improve diagnostic technologies, the PCR technologies industry will grow significantly in the coming years.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by technique
  • 1.4.3. Market size breakdown, by application
  • 1.4.4. Market size breakdown, by end user
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Technique (2017-2030)
• 6.4. Market Revenue, by Application (2017-2030)
• 6.5. Market Revenue, by End User (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Technique (2017-2030)
• 7.4. Market Revenue, by Application (2017-2030)
• 7.5. Market Revenue, by End User (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Technique (2017-2030)
• 8.4. Market Revenue, by Application (2017-2030)
• 8.5. Market Revenue, by End User (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Technique (2017-2030)
• 9.4. Market Revenue, by Application (2017-2030)
• 9.5. Market Revenue, by End User (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Technique (2017-2030)
• 10.4. Market Revenue, by Application (2017-2030)
• 10.5. Market Revenue, by End User (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Technique (2017-2030)
• 11.4. Market Revenue, by Application (2017-2030)
• 11.5. Market Revenue, by End User (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Technique (2017-2030)
• 12.4. Market Revenue, by Application (2017-2030)
• 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Technique (2017-2030)
• 13.4. Market Revenue, by Application (2017-2030)
• 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Technique (2017-2030)
• 14.4. Market Revenue, by Application (2017-2030)
• 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Technique (2017-2030)
• 15.4. Market Revenue, by Application (2017-2030)
• 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Technique (2017-2030)
• 16.4. Market Revenue, by Application (2017-2030)
• 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Technique (2017-2030)
• 17.4. Market Revenue, by Application (2017-2030)
• 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Technique (2017-2030)
• 18.4. Market Revenue, by Application (2017-2030)
• 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Technique (2017-2030)
• 19.4. Market Revenue, by Application (2017-2030)
• 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Technique (2017-2030)
• 20.4. Market Revenue, by Application (2017-2030)
• 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Technique (2017-2030)
• 21.4. Market Revenue, by Application (2017-2030)
• 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Technique (2017-2030)
• 22.4. Market Revenue, by Application (2017-2030)
• 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Technique (2017-2030)
• 23.4. Market Revenue, by Application (2017-2030)
• 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Technique (2017-2030)
• 24.4. Market Revenue, by Application (2017-2030)
• 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Technique (2017-2030)
• 25.4. Market Revenue, by Application (2017-2030)
• 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Technique (2017-2030)
• 26.4. Market Revenue, by Application (2017-2030)
• 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Technique (2017-2030)
• 27.4. Market Revenue, by Application (2017-2030)
• 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Technique (2017-2030)
• 28.4. Market Revenue, by Application (2017-2030)
• 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. F. Hoffmann-La Roche AG
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Thermo Fisher Scientific Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Bio-Rad Laboratories Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. QIAGEN N.V.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Takara Bio USA Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Agilent Technologies Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Standard BioTools Inc.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Danaher Corporation
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Abbott Laboratories
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Merck Life Science Private Limited
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Becton, Dickinson and Company
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Eppendorf AG
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports